A U.S. Food and Drug Administration (FDA) advisory committee recently determined that phenylephrine, an ingredient commonly used to treat sinus and nasal congestion, is ineffective in treating these symptoms. This was apparent from research for years, yet large...
El senador estadounidense Marco Rubio (R-FL) habló con César Grajales de La Poderosa 670 AM en El Panorama Político, sobre la crisis fronteriza, sobre cómo los hispanoamericanos se ven afectados con la realidad del país, sobre los cargos contra el senador Bob Menéndez...
Pregnant students are sometimes discriminated against by their schools, either intentionally or unintentionally and there is a concerning lack of awareness about the resources and rights available to them. Due to a lack of services and discrimination, these women may...
Currently, intelligence community civilians are subject to certain tax penalties for job-related relocation requirements, but active-duty military servicemembers are not subjected to the same penalties. These tax benefits, including the ability to deduct moving...
Vice Chairman of the Senate Select Committee on Intelligence Marco Rubio (R-FL) delivered opening remarks and questioned witnesses at a hearing on countering China’s influence in the United States. Watch Rubio’s opening remarks here as well as Part I and Part II of...
Approximately 302,000 Americans live with spinal cord injuries. To help these people achieve a better quality of life, there is a need to increase education and invest in research. U.S. Senators Marco Rubio (R-FL) and Tammy Baldwin (D-WI) successfully led a bipartisan...
Washington, D.C. — U.S. Senator Marco Rubio (R-FL) joined Senators Bob Menendez (D-NJ), Jeff Merkley (D-OR) and Chris Coons (D-DE) in filing an amendment to the China legislative package currently being debated on the Senate Floor. The amendment seeks to add a provision to the U.S. Innovation and Competition Act to ensure Hong Kongers who peacefully protested Beijing’s corrupt justice system, and have a well-founded fear of persecution, are eligible for Priority 2 Refugee status. The amendment stems from Rubio’s Hong Kong Safe Harbor Act, bipartisan legislation that was introduced earlier this year.
“The CCP is tightening its stranglehold on Hong Kong and with that comes the targeting of Hong Kong pro-democracy leaders and activists,” Rubio said. “We have already seen activists, including Joshua Wong, Agnes Chow, and others get dragged away to prison for nothing more than exercising the rights guaranteed to them. The U.S. must do all it can to assist those Hong Kongers who have courageously stood up to defend the city they love from the CCP’s persecution and open our doors to them. We must also continue to encourage like-minded nations to make similar accommodations in support of those Hong Kongers in need of safe harbor.”
“As we continue to debate how to best restructure and recalibrate U.S. policy towards China, we cannot lose sight of the need to meet our nation’s moral obligation to the people of Hong Kong,” Menendez said. “I am proud to be joined by my colleagues in this effort to ground our policies in our values, making it clear that we are committed to providing refuge to Hong Kong’s democratic activists, human rights activists, journalists and other Hong Kong citizens currently being targeted on trumped-up charges of sedition and national security violations.”
“As the Senate continues the important work of shaping comprehensive bipartisan policy towards China, it’s critical that we reaffirm our shared commitment to protect Hong Kongers facing persecution for exercising their fundamental rights,” Coons said. “ I’m proud to introduce this amendment with my colleagues that will send a clear message around the world that the United States stands by those fighting for democracy and freedom.”
Rubio is Vice Chairman of the Senate Select Committee on Intelligence and a member of the Senate Committee on Foreign Relations.
Menendez is the Chairman of the Senate Committee on Foreign Relations.
A copy of the senators’ amendment can be found here.